Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib mesylate in patients with recurrent Ewing sarcoma family tumors or desmoplastic small round cell tumor has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Ewing Sarcoma

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Sarcoma | Phase 2 | Status: COMPLETED